Scoring systems for clinical staging of peritoneal carcinomatosis: A critical analysis;Klinisches Staging der Peritonealkarzinose durch Scoringsysteme: Eine Kritische Analyse

Chirurg

Volumn 78, Issue 12, 2007, Pages 1091-1099

  Jahne J ^a   Kubler S ^a  

^a Henriettenstiftung   (Germany)

Author keywords

Classification; Clinical staging; Peritoneal carcinomatosis; Prognosis

Indexed keywords

ARTICLE; CANCER STAGING; GASTROINTESTINAL TUMOR; HUMAN; METASTASIS; METHODOLOGY; MINIMAL RESIDUAL DISEASE; PATHOLOGY; PERITONEUM TUMOR; PROGNOSIS; REOPERATION; TUMOR VOLUME;

GASTROINTESTINAL NEOPLASMS; HUMANS; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PERITONEAL NEOPLASMS; PROGNOSIS; REOPERATION; TUMOR BURDEN;

EID: 36849090961     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-007-1426-1     Document Type: Article

References (44)

1. Sugarbaker PH, Chang D (1999) Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6: 727-731
2. Elias D, Sideris L, Pocard M et al. (2004) Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis. Preliminary results in 24 patients. Ann Oncol 15: 781-785
3. Beaujard AC, Glehen O, Caillot JL et al. (2000) Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 88: 2512-2519
4. Carmignani CP, Sugarbaker PH (2004) Synchronous extraperitoneal and intraperitoneal dissemination of appendix cancer. Eur J Surg Oncol 30: 864-868
5. Cavaliere F, Perri P, Di Filippo F et al. (2000) Treatment of peritoneal carcinomatosis with intent to cure. J Surg Oncol 74: 41-44
6. Ceelen WP, Hesse U, Hemptinne B de, Pattyn P (2000) Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer. Br J Surg 87: 1006-1015
7. Bree E de, Koops W, Kröger R et al. (2004) Peritoneal carcinomatosis from colorectal or appendiceal origin: Correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol 86: 64-73
8. Bree E de, Koops W, Kröger R et al. (2006) Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 32: 65-71
9. Elias D, Blot F, El Otmany A et al. (2001) Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 92: 71-76
10. Glehen O, Cotte E, Schreiber V et al. (2004) Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin. Br J Surg 91: 747-754
11. Glehen O, Kwiatkowski F, Sugarbaker PH et al. (2004) Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22: 3284-3292
12. Glehen O, Mohamed F, Gilly FN (2004) Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol 5: 219-228
13. Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In: Sugarbaker PH (ed) Peritoneal Carcinomatosis: Principles of Management. Kluwer Academic Publishers, Boston, pp 359-374
14. Deraco M, Baratti D, Inglese MG et al. Peritonectomy and Intraperitoneal Hyperthermic Perfusion (IPHP) (2004) A strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol 11: 393-398
15. Ahmad SA, Kim J, Sussman JJ et al. (2004) Reduced morbidity following cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion. Ann Surg Oncol 11: 387-392
16. Elias D, Matsuhisa T, Sideris L et al. (2004) Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance. Ann Oncol 15: 1558-1565
17. Glehen O, Mohamed F, Sugarbaker PH (2004) Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy. Ann Surg 240: 278-285
18. Miner TJ, Shia J, Jaques DP et al. (2005) Long-term survival following treatment of pseudomyxoma peritonei. Ann Surg 241: 300-308
19. Shen P, Hawksworth J, Lovato J et al. (2004) Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol 11: 178-186
20. Verwaal VJ, Boot H, Aleman BMP et al. (2004) Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: Location, treatment, and outcome. Ann Surg Oncol 11: 375-379
21. Yan TD, Haveric N, Carmignani CP et al. (2005) Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Cancer 103: 839-849
22. Pestieau SR, Sugarbaker PH (2000) Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant versus delayed management. Dis Colon Rectum 43: 1341-1346
23. Younan R, Kusamura S, Baratti D et al. (2005) Complications in 203 cases of peritoneal surface malignancies treated with peritonectomy and closed-technique intraperitoneal hyperthermic perfusion. Ann Surg Oncol 12: 910-918
24. Glehen O, Gilly FN (2003) Quantitative prognostic indicators of peritoneal surface malignancy: carcinomatosis, sarcomatosis, and peritoneal mesothelioma. Surg Oncol Clin N Am 12: 649-671
25. Japanese research society for gastric cancer (1981) The general rules for the gastric cancer study in surgery and pathology. Japn J Surg 11: 127-139
26. Gilly FN, Carry PY, Sayag AC (1994) Regional chemotherapy with mitomycin C and intraoperative hyperthermia for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterology 41: 124-129
27. Jacquet P, Sugarbaker PH (1996) Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res 15: 49-58
28. Harmon RL, Sugarbaker PH (2005) Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol 2: 3
29. Tentes AAK, Tripsiannis G, Markakidis SK et al. (2003) Peritoneal cancer index: a prognostic indicator of survival in advanced ovarian cancer. Eur J Surg Oncol 29: 69-73
30. Verwaal VJ, Tinteren H van, Ruth S van, Zoetmulder FAN (2004) Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy. Br J Surg 91: 739-746
31. Yan TD, Haveric N, Carmignani CP et al. (2005) Computed tomographic characterization of malignant peritoneal mesothelioma. Tumori 91: 394-400
32. Verwaal VJ, Ruth S van, Bree E de et al. (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21: 3737-3743
33. Fujimoto S, Takahashi M, Mutou T et al. (1997) Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer 79: 884-891
34. Kusamura S, Younan R, Dario Baratti D et al.(2006) Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion. Cancer 106: 1144-1153
35. Loungnarath R, Causeret S, Bossard N et al. (2005) Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: A prospective study. Dis Colon Rectum 48: 1372-1379
36. Mahteme H, Sugarbaker PH (2004) Treatment of peritoneal carcinomatosis from adenocarcinoid of appendiceal origin. Br J Surg 91: 1168-1173
37. Nonaka D, Kusamura S, Baratti D et al. (2005) Diffuse malignant mesothelioma of the peritoneum. Cancer 104: 2181-2188
38. Pestieau SR, Jelinek JS, Chang D et al. (2000) CT in the selection of patients with abdominal or pelvic sarcoma for reoperative surgery. J Am Coll Surg 190: 700-710
39. Portilla AG, Sugarbaker PH, Chang D (1999) Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: Analysis of prognostic features. World J Surg 23: 23-29
40. Sebbag G, Yan H, Shmookler M et al. (2000) Results of treatment of 33 patients with peritoneal mesothelioma. Br J Surg 87: 1587-1593
41. Sugarbaker PH (2002) Intraperitoneal chemotherapy for treatment and prevention of peritoneal carcinomatosis and sarcomatosis. Semin Oncol 29: 51-61
42. Shen P, Levine EA, Hall J et al. (2003) Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch Surg 138: 26-33
43. Sugarbaker PH (1999) Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol Suppl 43: S15-S25
44. Loggie BW, Fleming RA, McQuellon RP et al. (2000) Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am Surg 66: 561-568